Global Peptide Therapeutics Market to Be Fueled by Increasing Prevalence of Cancer and Diabetes

Peptide Therapeutics Market (by Applications, by Route of Administration, and by Marketing Status) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

Peptide Therapeutics Market Expected to Reach USD 23.7 Billion Globally in 2020

According to a new market report published by Transparency Market Research “Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” the global peptide therapeutics market was valued at USD 18.9 billion in 2013 and is estimated to reach USD 23.7 billion by 2020 at a CAGR of 2.8% from 2014 to 2020.

Browse the full   Peptide Therapeutics Market Report at

Therapeutic peptides have been approved for various indications including metabolic disorders, hematological disorders, cancer, cardiovascular disorders, central nervous system disorders, infection, gastrointestinal disorders, respiratory disorders, acromegaly, and others. Such diverse areas of application dictate efficiency of peptides in medical treatment. Increasing research and development activities towards exploration of novel peptides with better therapeutic effect has resulted in a rich pipeline. Animal sources such as venom have been major sources of peptides for research. Scientists are also trying various microbial sources for discovery of novel peptides with therapeutic effect. Despite extensive research efforts, oral delivery of therapeutic peptides or proteins is still a challenge for researchers, due to unfavorable physiological conditions such as acidic pH and presence of proteolytic enzymes. Moreover, low permeability of peptides across the intestinal barrier is a factor adding to the low bioavailability.


Since 2001, over 19 new therapeutic peptides have been approved in the U.S., of these eight were approved in 2012, according to a review article published in the Drug...